94
97M
76
4.95
9
0.19
47
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Windermere. The company was established in North America in United States.
The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight AveXis, Passage Bio, Codiak Biosciences. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Medical, Therapeutics. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Comparing to the other companies, this Boxer Capital performs on 21 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2019. The fund is constantly included in 2-6 deals per year. The important activity for fund was in 2019. Deals in the range of 50 - 100 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations.
The typical case for the fund is to invest in rounds with 8-9 participants. Despite the Boxer Capital, startups are often financed by OrbiMed, Vivo Capital, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are RA Capital Management, Alexandria Venture Investments, Vivo Capital. In the next rounds fund is usually obtained by RA Capital Management, Tavistock Life Sciences, Surveyor Capital.
We also calculated 3 valuable employees in our database.
Investments analytics
Analytics
- Total investments
- 94
- Lead investments
- 9
- Exits
- 47
- Rounds per year
- 4.95
- Follow on index
- 0.19
- Investments by industry
- Biotechnology (86)
- Therapeutics (50)
- Health Care (48)
- Life Science (23)
- Medical (23) Show 16 more
- Investments by region
-
- United States (82)
- France (1)
- United Kingdom (2)
- Ireland (1)
- Austria (1) Show 3 more
- Peak activity year
- 2020
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 3
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 87M
- Group Appearance index
- 0.99
- Avg. company exit year
- 3
- Avg. multiplicator
- 2.03
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ajax Therapeutics | 13 May 2024 | Biotechnology, Medical, Life Science | Late Stage Venture | 95M | United States, Massachusetts, Cambridge |
| Seismic Therapeutic | 09 Feb 2022 | Early Stage Venture | 101M |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.